MyoPharm is a biotechnology company that offers pharmaceutical companies a proven-effective method of analyzing their compounds during pre-clinical stages for clinical trial efficacy, thus presenting a significant cost-cutting opportunity and lowering attrition risk during the clinical trial stage.
We are an innovative developer of 3D-bioprinting technology for the development of organs-on-chip for compound screening and tissue engineering. We will develop a prototype of the organ's tissue for further product testing, development, and market commercialization.
Company Details
- Employees
- 4
- Address
- 2 Simcoe Street South, Suite 300,canada
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://myopharm.ca
- Keywords
- Tehran.
- HQ
- Oshawa
- Competitors
- Tissue Engineering & Applied Cell Sciences, Tissue Engineering, Parts A, B, & C, Cytograft Tissue Engineering, Inc., Tissue Engineering Today, Tissue Engineering and Regenerative Medicine Hub - UAS Technikum Wien, Punctual, Lunie (acquired by Blockdaemon 🎉), Minor in BioMed Entrepreneurship, ARKAY Therapeutics, Myopharm Limited.
Myopharm Questions
Myopharm's website is https://myopharm.ca
Myopharm's LinkedIn profile is https://ca.linkedin.com/company/myopharm
Myopharm has
4 employees.
View email and phone details for 4
employees at Myopharm.
Myopharm's industry is
Biotechnology Research
Myopharm's top competitors are
Tissue Engineering & Applied Cell Sciences,
Tissue Engineering, Parts A, B, & C,
Cytograft Tissue Engineering, Inc.,
Tissue Engineering Today,
Tissue Engineering And Regenerative Medicine Hub - Uas Technikum Wien,
Punctual,
Lunie (Acquired By Blockdaemon 🎉),
Minor In Biomed Entrepreneurship,
Arkay Therapeutics,
Myopharm Limited.
Myopharm's categories are Biotechnology Research
